Walleye Trading LLC Rigel Pharmaceuticals Inc Transaction History

Walleye Trading LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$1.78 - $4.13 $26,700 - $61,950	-15,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.41 - $2.05 $21,150 - $30,749	15,000 New	15,000 $27,000
Q4 2018 Feb 14, 2019	SELL	$2.08 - $3.36 $486,004 - $785,084	-233,656 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$2.6 - $3.59 $71,208 - $98,322	27,388 Added 13.28%	233,656 $750,000
Q2 2018 Aug 14, 2018	BUY	$2.83 - $4.11 $583,738 - $847,761	206,268 New	206,268 $584,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $4.77B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.